Periodontal Disease Treatment Market

The periodontal disease treatment market is projected to reach USD 3.86 billion by 2031 from USD 2.86 billion in 2026, at a CAGR of 6.2% during the forecast period.

The most significant driving factor for the periodontal disease treatment market is the rise in the number of people affected by gum diseases due to unhygienic oral practices, the increased incidence of smoking, improper diet practices, and the rise in the number of people experiencing systemic diseases, like an increased incidence of diabetes, which has impacted periodontal diseases. In addition, awareness of the importance of oral practices and the association of periodontal diseases with systemic diseases has influenced people in seeking appropriate treatment for periodontal diseases. Advancements in dental technology, such as the increased acceptance of minimally invasive dentistry, laser technology in periodontal treatment, and improvements in periodontal devices, have also made periodontal treatments more efficient and more acceptable for practitioners and patients.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the market are Dentsply Sirona (US), Henry Schein, Inc. (US), Nakanishi Inc. (Japan), Yoshida Dental MFG. Co., Ltd. (Japan), Institut Straumann Holdings AG (Switzerland), Envista Holdings Corporation (US), and BIOLASE, Inc. (US). These players have a very strong position in the periodontal disease treatment market because of their comprehensive and diversified portfolios, strong distribution networks, and long-term relationships and associations with dental practices, hospitals, and academic institutes. This helps them integrate their periodontal products very effectively. They have a very strong brand name in the field of dentistry.

In addition, they have made consistent investments in research and development. This helps them innovate new products such as minimally invasive treatments, precision instruments, digital dentistry connectivity, and regenerative periodontal treatments. For example, in October 2025, BIOLASE showcased a YSGG laser-assisted periodontitis treatment protocol at the AAP 2025 Corporate Forum, highlighting a minimally invasive approach that improves bacterial reduction, preserves healthy tissue, and enhances healing outcomes in periodontal pocket treatment. In July 2025, Envista expanded its manufacturing footprint with a new facility in China to strengthen regional supply, improve operational efficiency, and support growing demand for dental and periodontal care products in the Asia Pacific market.

Dentsply Sirona (US) is a major dental equipment and consumables manufacturer on a global scale. The company is well-positioned in the periodontal disease treatment market through the availability of a complete product and technology range that enables periodontal care. Being the world's largest supplier of professional dental solutions, the company provides tools and consumables for periodontal scaling, maintenance therapy, and adjunctive treatments, along with advanced dental lasers that help in bacterial reduction and soft tissue management during periodontal procedures. Dentsply Sirona's diversified portfolio is combined with digital dentistry workflows and backed by large investments in R&D and clinician education that allow dental professionals to provide effective, evidence-based periodontal treatments.

Henry Schein, Inc. (US) is a world leader in offering comprehensive healthcare solutions to dentists and medical professionals worldwide, and through this, the company has a considerable presence in the periodontal treatments segment with its diversified range of periodontal care solutions. Henry Schein offers a diversified range of periodontal care solutions, including periodontal care instruments, prophylaxis solutions, infection control solutions, and various other periodontal care solutions that help treat the diseases effectively, along with various dental care solutions to help increase the efficiency and comfort level of the patients. Henry Schein uses its wide distribution channel to provide services to small and large dental setups with access to high-quality periodontal care solutions and related value-added services like clinical and management aid, and evidence-based educational materials to help medical and dental practitioners keep themselves updated with the recent developments related to the periodontal treatments available worldwide.

MARKET RANKING

In the periodontal disease treatment market, Dentsply Sirona (US) is at the forefront as a result of its extensive portfolio of periodontal instruments, consumables, and digital dentistry solutions that facilitate both non-surgical and surgical care. Next in line is Henry Schein, Inc. (US), which is capitalizing on its robust distribution network and comprehensive range of periodontal products and value-added services for dental practices. Nakanishi Inc. (Japan) has a powerful position in the middle market as a result of its dominance in high-precision dental handpieces, which are highly functional in periodontal procedures. Yoshida Dental MFG. Co., Ltd. (Japan) has a stable position, which is backed by its longstanding dental equipment installations and solid foothold in the Asian market. Institut Straumann Holdings AG (Switzerland) is one of the companies with a niche hold, primarily due to the company's focus on regenerative and implant-related products, which are very relevant to advanced periodontal and peri-implant therapies.